Literature DB >> 19505562

Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain.

Syed Waseem Bihaqi1, Meenakshi Sharma, Avninder Pal Singh, Manisha Tiwari.   

Abstract

AIM OF THE STUDY: Convolvulus pluricaulis (Convolvulaceae) has long been used as traditional herbal medicine in India as nerve tonic. We investigated neuroprotective effects of aqueous extract from Convolvulus pluricaulis (CP) against aluminium chloride induced neurotoxicity in rat cerebral cortex. MATERIAL, METHOD AND RESULT: Daily administration of CP (150 mg/kg) for 3 months along with aluminium chloride (50 mg/kg) decreased the elevated enzymatic activity of acetylcholine esterase and also inhibited the decline in Na(+)/K(+)ATPase activity which resulted from aluminium intake. Beside, preventing accumulation of lipid and protein damage, changes in the levels of endogenous antioxidant enzymes associated with aluminium administration were also rectified. Oral administration of CP preserved the mRNA levels of muscarinic receptor 1 (M1 receptor), choline acetyl transferase (ChAT) and Nerve Growth Factor-Tyrosine kinase A receptor (NGF-TrkA). It also ameliorated the upregulated protein expression of cyclin dependent kinase5 (Cdk5) induced by aluminium. The potential of CPE to inhibit aluminium induced toxicity was compared with rivastigmine tartrate (1mg/kg), which was taken as standard. The potential of the extract to prevent aluminium-induced neurotoxicity was also reflected at the microscopic level, indicative of its neuroprotective effects.
CONCLUSION: Convolvulus pluricaulis possesses neuroprotective potential, thus validating its use in alleviating toxic effects of aluminium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19505562     DOI: 10.1016/j.jep.2009.05.038

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  27 in total

1.  Augmentation of aluminum-induced oxidative stress in rat cerebrum by presence of pro-oxidant (graded doses of ethanol) exposure.

Authors:  Prasunpriya Nayak; Shiv Bhushan Sharma; Nadella Vijaya Subbaraya Chowdary
Journal:  Neurochem Res       Date:  2010-07-18       Impact factor: 3.996

2.  The possible neuroprotective effects of melatonin in aluminum chloride-induced neurotoxicity via antioxidant pathway and Nrf2 signaling apart from metal chelation.

Authors:  Kadry M Sadek; Mohamed A Lebda; Tarek K Abouzed
Journal:  Environ Sci Pollut Res Int       Date:  2019-02-04       Impact factor: 4.223

3.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

Review 4.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

5.  Protective effects of a piperazine derivative [N-{4-[4-(2-methoxy-phenyl)-piperazin-1-yl]-phenyl} carbamic acid ethyl ester] against aluminium-induced neurotoxicity: insights from in silico and in vivo studies.

Authors:  Poonam Meena; Apra Manral; Vikas Saini; Manisha Tiwari
Journal:  Neurotox Res       Date:  2014-11-18       Impact factor: 3.911

Review 6.  An update on Ayurvedic herb Convolvulus pluricaulis Choisy.

Authors:  Parul Agarwa; Bhawna Sharma; Amreen Fatima; Sanjay Kumar Jain
Journal:  Asian Pac J Trop Biomed       Date:  2014-03

Review 7.  Neurotoxic effects of aluminium exposure as a potential risk factor for Alzheimer's disease.

Authors:  Mangaldeep Dey; Rakesh Kumar Singh
Journal:  Pharmacol Rep       Date:  2022-01-27       Impact factor: 3.024

8.  Supplementation of Convolvulus pluricaulis attenuates scopolamine-induced increased tau and amyloid precursor protein (AβPP) expression in rat brain.

Authors:  Syed Waseem Bihaqi; Avninder Pal Singh; Manisha Tiwari
Journal:  Indian J Pharmacol       Date:  2012 Sep-Oct       Impact factor: 1.200

9.  Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease.

Authors:  Manal Fouad Ismail; Aliaa Nabil Elmeshad; Neveen Abdel-Hameed Salem
Journal:  Int J Nanomedicine       Date:  2013-01-23

10.  Ayurvedic medicinal plants for Alzheimer's disease: a review.

Authors:  Rammohan V Rao; Olivier Descamps; Varghese John; Dale E Bredesen
Journal:  Alzheimers Res Ther       Date:  2012-06-29       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.